MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9. (Q46606607)

23 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9. (English)

1 reference

23 December 2017

1 reference

Jian-Qiang Xu

1

1 reference

23 December 2017

Wei-Bin Zhang

series ordinal

2

1 reference

23 December 2017

Rong Wan

series ordinal

3

1 reference

23 December 2017

Yao-Qi Yang

series ordinal

4

1 reference

23 December 2017

publication date

3 July 2014

1 reference

23 December 2017

published in

Tumor Biology

1 reference

23 December 2017

volume

35

1 reference

23 December 2017

page(s)

9847-9853

1 reference

23 December 2017

issue

10

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s13277-014-2229-x

exact match

0 references

cites work

Osteosarcoma treatment - where do we stand? A state of the art review.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Recent advances in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Adult-specific functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Diversifying microRNA sequence and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

MicroRNA function and dysregulation in bone tumors: the evidence to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Methylation of human microRNA genes in normal and neoplastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

DNA methylation and microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

All purpose Sox: The many roles of Sox proteins in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Oncogenicity of the developmental transcription factor Sox9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Expression of SOX9 and SOX10 in central neuroepithelial tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

The transcriptional control of trunk neural crest induction, survival, and delamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2229-X

microRNA-32 inhibits the proliferation and invasion of the SGC-7901 gastric cancer cell line in vitro

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24989927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2229-X

1 reference

23 December 2017

PubMed ID

24989927

1 reference

23 December 2017